Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes

Hodgkin’s lymphoma is a rare yet highly curable disease in the majority of patients treated with modern chemotherapy regimens. For patients who fail to respond to or relapse after initial systemic therapies, treatment with high-dose chemotherapy and autologous hematopoietic stem cell transplantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Juhaishi, Taha, Borogovac, Azra, Ibrahimi, Sami, Wieduwilt, Matthew, Ahmed, Sairah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880200/
https://www.ncbi.nlm.nih.gov/pubmed/35207613
http://dx.doi.org/10.3390/jpm12020125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880200/
https://www.ncbi.nlm.nih.gov/pubmed/35207613
http://dx.doi.org/10.3390/jpm12020125

Ejemplares similares